REFERENCES
- Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50:231–244
- Mackensen F, Becker MD, Wiehler U, et al. QuantiFERON TB-Gold—a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis. Am J Ophthalmol. 2008;146:761–766
- Akpek EK, Baltatzis S, Yang J, et al. Longterm immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm. 2001;9:153–167
- Baglivo E, Boudjema S, Pieh C, et al. Vascular occlusion in serpiginous choroidopathy. Br J Ophthalmol. 2005;89:387–388
- Markomichelakis NN, Halkiadakis I, Papaeythymiou-Orchan S, et al. Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis. Ocul Immunol Inflamm. 2006;14:29–33
- Araujo AA, Wells AP, Dick AD, et al. Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol. 2000;84:979–982
- Akpek EK, Jabs DA, Tessler HH, et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109:1506–1513
- Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944–951
- Seve P, Mennesson E, Grange JD, et al. Infliximab in serpiginous choroiditis. Acta Ophthalmol. 2010;88:342–243
- Cordero-Coma M, Benito MF, Hernández AM, et al. Serpiginous choroiditis. Ophthalmology. 2008;115:1633